Abstract
The effect of glycine in preventing diabetes teratogenicity was studied in mice. Pregnant female animals were given an IP injection of 200mg/kg of streptozotocin (STZ) on gestation day (GD) 7. Glycine was administered ad libitum from GD9 through GD19 (day of sacrifice) as a 1 and 2% drinking water solution. Nine whole-litter resorptions, a decreased number of live fetuses and fetal parameters, and an increase in HbA1C levels in diabetic dams were found. Malformations were limited. Glycine had a protective effect from hemoglobin glycation and embryotoxicity due to STZ-induced diabetes. Also, resorptions and malformed fetuses were positively correlated to HbA 1C levels with a negative correlation to the number of live fetuses. The data suggest that glycine reduces the embryolethality of STZ-induced diabetes due to its anti-glycation effect.
Original language | English |
---|---|
Pages (from-to) | 449-453 |
Number of pages | 5 |
Journal | Pharmaceutical Biology |
Volume | 41 |
Issue number | 6 |
DOIs | |
State | Published - Sep 2003 |
Keywords
- Diabetes
- Embryotoxicity
- Glycation
- Glycine
- Teratogenesis